132 related articles for article (PubMed ID: 23998567)
1. Rapid detection of AML1 associated fusion genes in patients with adult acute myeloid leukemia and its clinical significance.
Jiang MM; Gao L; Jing Y; Ding Y; Xu YY; Zhou MH; Ma C; Wang N; Wang W; Han XP; Li HH; Wang QS; Wang LL; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):821-9. PubMed ID: 23998567
[TBL] [Abstract][Full Text] [Related]
2. Monitoring the AML1/ETO fusion transcript to predict outcome in childhood acute myeloid leukemia.
Zhang L; Cao Z; Ruan M; Zeng Q; Zhao L; Li Q; Zou Y; Wang J; Zhu X
Pediatr Blood Cancer; 2014 Oct; 61(10):1761-6. PubMed ID: 24920269
[TBL] [Abstract][Full Text] [Related]
3. [Detection of aml-1/eto fusion gene in patients with acute myeloid leukemia by real-time quantitative RT-PCR].
Jiang YM; Yuan H; Liu XY; Wang B; Li SJ; Wang N
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):17-22. PubMed ID: 19236739
[TBL] [Abstract][Full Text] [Related]
4. [Application of multiplex nested RT- PCR assay for screening the fusion genes in acute myeloid leukemia and its clinical significance].
Xu Y; Gao L; Sun J; Ding Y; Xu Y; Lyu C; Liu W; Wang N; Wang L; Yu L
Zhonghua Xue Ye Xue Za Zhi; 2014 Jan; 35(1):29-34. PubMed ID: 24602728
[TBL] [Abstract][Full Text] [Related]
5. Quantification of AML1-ETO fusion transcript as a prognostic indicator in acute myeloid leukemia.
Yoo SJ; Chi HS; Jang S; Seo EJ; Seo JJ; Lee JH; Park HS; Park CJ
Haematologica; 2005 Nov; 90(11):1493-501. PubMed ID: 16266896
[TBL] [Abstract][Full Text] [Related]
6. Monitoring of minimal residual disease (MRD) by real-time quantitative reverse transcription PCR (RQ-RT-PCR) in childhood acute myeloid leukemia with AML1/ETO rearrangement.
Viehmann S; Teigler-Schlegel A; Bruch J; Langebrake C; Reinhardt D; Harbott J
Leukemia; 2003 Jun; 17(6):1130-6. PubMed ID: 12764380
[TBL] [Abstract][Full Text] [Related]
7. [Long-term survival analysis in 89 adult patients with acute myeloid leukemia of fusion gene aml1/eto positive].
Fang YH; Liu HX; Tong CR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Jun; 17(3):750-5. PubMed ID: 19549401
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of AML 1/ETO fusion transcripts in patients with acute myelogenous leukemia.
Cho EK; Bang SM; Ahn JY; Yoo SM; Park PW; Seo YH; Shin DB; Lee JH
Korean J Intern Med; 2003 Mar; 18(1):13-20. PubMed ID: 12760263
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of 21 children with acute non-lymphoid leukemia carrying AML1/ETO fusion gene].
Zhao W; Li ZG; Wu MY; Geng LZ; Shi HW; Zhang YH; Wu RH
Zhonghua Er Ke Za Zhi; 2003 May; 41(5):325-8. PubMed ID: 14751048
[TBL] [Abstract][Full Text] [Related]
10. [Clinical significance of detection of AML1/ETO fusion transcripts in childhood AML using real-time quantitative reverse transcription polymerase chain reaction].
Liu CF; Liu GL; Zhang LP; Cheng YF; Lu AD; Tian KG; Liu YR; Qin YZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Feb; 13(1):76-82. PubMed ID: 15748440
[TBL] [Abstract][Full Text] [Related]
11. [Role of molecular screening for common fusion genes in the diagnosis and classification of leukemia].
Zhu YL; Zhang Y; Zhu P; Yang Y; Du JW; Liu J
Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Jun; 37(3):236-9. PubMed ID: 15968309
[TBL] [Abstract][Full Text] [Related]
12. Detection of minimal residual disease in patients with AML1/ETO-associated acute myeloid leukemia using a novel quantitative reverse transcription polymerase chain reaction assay.
Marcucci G; Livak KJ; Bi W; Strout MP; Bloomfield CD; Caligiuri MA
Leukemia; 1998 Sep; 12(9):1482-9. PubMed ID: 9737700
[TBL] [Abstract][Full Text] [Related]
13. High expression of c-kit mRNA predicts unfavorable outcome in adult patients with t(8;21) acute myeloid leukemia.
Gao X; Lin J; Gao L; Deng A; Lu X; Li Y; Wang L; Yu L
PLoS One; 2015; 10(4):e0124241. PubMed ID: 25860287
[TBL] [Abstract][Full Text] [Related]
14. Monitoring of minimal residual disease in acute myeloid leukemia with t(8;21)(q22;q22).
Zhang L; Li Q; Li W; Liu B; Wang Y; Lin D; Zhou C; Li C; Wang J; Mi Y
Int J Hematol; 2013 Jun; 97(6):786-92. PubMed ID: 23613269
[TBL] [Abstract][Full Text] [Related]
15. [Monitoring AML1-ETO mRNA levels by real-time quantitative RT-PCR in t(8;21) acute myeloid leukemia patients after hematopoietic stem cell transplantation].
Wang ZD; Qin YZ; Liu YR; Xu LP; Liu DH; Liu KY; Huang XJ
Zhonghua Xue Ye Xue Za Zhi; 2008 Oct; 29(10):672-5. PubMed ID: 19176061
[TBL] [Abstract][Full Text] [Related]
16. [Significance of quantification of WT1 mRNA for monitoring minimal residual disease in acute myeloid leukemia patients].
Qin YZ; Ruan GR; Li JL; Fu JY; Chang Y; Wang H; Li LD; Liu YR; Chen SS
Zhonghua Xue Ye Xue Za Zhi; 2005 Nov; 26(11):649-52. PubMed ID: 16620548
[TBL] [Abstract][Full Text] [Related]
17. Quantitative detection of AML1-ETO rearrangement by real-time RT-PCR using fluorescently labeled probes.
Barragán E; Bolufer P; Moreno I; Martín G; Nomdedeu J; Brunet S; Fernández P; Rivas C; Sanz MA
Leuk Lymphoma; 2001 Aug; 42(4):747-56. PubMed ID: 11697505
[TBL] [Abstract][Full Text] [Related]
18. AML1/ETO fusion mRNA can be detected in remission blood samples of all patients with t(8;21) acute myeloid leukemia after chemotherapy or autologous bone marrow transplantation.
Kusec R; Laczika K; Knöbl P; Friedl J; Greinix H; Kahls P; Linkesch W; Schwarzinger I; Mitterbauer G; Purtscher B
Leukemia; 1994 May; 8(5):735-9. PubMed ID: 7514242
[TBL] [Abstract][Full Text] [Related]
19. The quality of molecular response to chemotherapy is predictive for the outcome of AML1-ETO-positive AML and is independent of pretreatment risk factors.
Weisser M; Haferlach C; Hiddemann W; Schnittger S
Leukemia; 2007 Jun; 21(6):1177-82. PubMed ID: 17377588
[TBL] [Abstract][Full Text] [Related]
20. [Expression of AML1/ETO9a isoform in acute myeloid leukemia-M2 subtype].
Miao YQ; Chen ZX; He J; Cen JN; Bao XJ; Qiu QC; Zhang DE; Yan M
Zhonghua Xue Ye Xue Za Zhi; 2007 Jan; 28(1):27-9. PubMed ID: 17649722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
